Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.

Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00731Source: DataRank Database

Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer is a research paper published in Journal of Medicinal Chemistry (2021). On theSindex it has a DataRank of 0.993. It has been cited 26 times, with 24 citing works in its 1-hop citation network.

N/A

0.993DataRank · unranked

0.993

26 citations · base score 3.3

Cite:

datarank_citation_only_1hop_v6· scope data_onlyMethodology

›Data sources & pipeline

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Pending

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

DataRank Breakdown

Base Score 50%Citation Network 50%

Base Score Contribution

0.494

From this paper's citation signal

Citation Network Contribution

0.499

From 22 citing papers with measurable signal

Learn more about DataRank methodology →

Top 2 citers driving the network score

Ranked by citation count — the same ordering the engine uses when summing log1p(C_q) over citers.

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Advanced Drug Delivery Reviews199711,102 citationsDataRank 1.4
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
Journal of Medicinal Chemistry20027,942 citationsDataRank 1.3

Why this DataRank?

DataRank blends this paper's own citation count with the influence of the papers that cite it. Here, roughly 50% comes from its base citations and 50% from the citation network (22 citing papers contributed measurable signal).

Base score B(p): log1p(citation_count) — grows sub-linearly, so a paper with 1,000 citations is not 10× a paper with 100.
Network N(p): Σ over citers of log1p(C_q) ÷ max(outdegree_q, 1). Being cited by a highly-cited paper with few references counts most.
Damping factor d = 0.85: DataRank = (1−d)·B(p) + d·N(p) — the two cards above are each already multiplied by their share.
Self-citations excluded: Citers sharing any OpenAlex author ID with this paper are filtered out before the network sum.

Citers are pulled from OpenAlex sorted by cited_by_count:descand capped per paper, so when the cap binds we keep the highest-signal references and the score is reproducible across reruns.

Read the full methodology →

Click a node to highlight its connections. Use scroll to zoom. Drag to pan.

Node colors:CenterData PaperData + Open AccessNon-dataSelected & links| Node size = percentile rank